Parker Paul Gray — SEC Form 4 filings

SEC reporting owner CIK 1833033. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-02.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-04-02 to 2026-03-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CLOROX CO /DE/ (CLX)Director36
Generate Biomedicines, Inc. (GENB)Director11

Form 4 filings — Parker Paul Gray

FiledFormIssuerReported transactionsSource
2026-03-024Generate Biomedicines, Inc. (GENB)Grant/award (A): 29,561 (derivative) @ $0EDGAR
2024-10-024CLOROX CO /DE/ (CLX)Grant/award (A): 80 @ $162.91 · Grant/award (A): 25.09 (derivative) @ $0EDGAR
2024-07-024CLOROX CO /DE/ (CLX)Grant/award (A): 96 @ $136.47 · Grant/award (A): 27.03 (derivative) @ $0EDGAR
2024-04-024CLOROX CO /DE/ (CLX)Grant/award (A): 85 @ $153.11 · Grant/award (A): 25.09 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1833033 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →